No long-term benefit of low-dose OKT3 induction therapy in non to moderately immunized renal allograft recipients

By Bemelman F.J.   Yong S.   Parlevliet K.J.   Surachno S.   Schellekens P.T.A.   ten Berge R.J.M.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3165-3167

Elsevier

Access to resources Recommend Favorite

Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin’s lymphoma

By Hess Georg   Flohr Thomas   Kolbe Karin   Bonn Sarah   Schuler Martin   Derigs Hans   Huber Christoph  

Annals of Hematology, Vol. 85, Iss. 11, 2006-11 ,pp. : 769-779

Springer Publishing Company

Access to resources Recommend Favorite

Induction of Long-Term Small Bowel Graft Survival by Low-Dose Immunosuppression in Tolerized Recipient Rats

By Chen H.   Xu D.   Qi S.   Busque S.   Tan A.   Daloze P.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 697-698

Elsevier

Access to resources Recommend Favorite

Long-Term Low-Dose IL-2 Enhances Immune Function in Common Variable Immunodeficiency

By Cunningham-Rundles C.   Bodian C.   Ochs H.D.   Martin S.   Reiter-Wong M.   Zhuo Z.  

Clinical Immunology, Vol. 100, Iss. 2, 2001-08 ,pp. : 181-190

Academic Press

Access to resources Recommend Favorite

Cytomegalovirus disease prophylaxis in renal transplantation by high dose oral acyclovir: efficacy and limits

By Bertoni E.   Rosati A.   Zanazzi M.   Moscarelli L.   Di Maria L.   Piperno R.   Orsi A.   Parri F.   Dedola G.   Salvadori M.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2094-2094

Elsevier

Access to resources Recommend Favorite